A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and Efficacy of FURESTEM-OA-Kit Inj. in Knee Osteoarthritis Patients Who Received Placebo in the K0701 Phase 2a Trial

Sponsor
Kang Stem Biotech Co., Ltd.
Study ID
NCT07754175
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
19 Years - N/A
Healthy Volunteers
Not accepted

Study Details

A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and Efficacy of FURESTEM-OA-Kit Inj. in Knee Osteoarthritis Patients Who Received Placebo in the K0701 Phase 2a Trial

Key Dates

First listed
Aug 10, 2026
Start date
Jul 20, 2026
Status verified
Jul 2026
Primary completion
Dec 31, 2031
Completion
Feb 28, 2032

Study Design

Enrollment
36 participants (estimated)

Primary Outcome Measure

Incidence of Adverse Event, AESI(Adverse Event of Special Interest) [ Time Frame: 5 years follow-up after treatment ]

Central Contacts

Find similar trials

Nationwide
Osteoarthritis (other) trialsOrthopedics trialsMusculoskeletal disorders trials

Related Studies